Wenjuan Huang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Outcomes and predictors of relapse and severe pneumonia in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder receiving inebilizumab: a prospective cohort study.
Journal: Frontiers in immunology
Published: October 04, 2025
CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells.
Journal: Frontiers in immunology
Published: September 12, 2025
Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder.
Journal: Frontiers in immunology
Published: September 12, 2025
Eculizumab for the acute attack of neuromyelitis optica spectrum disorder.
Journal: Frontiers in immunology
Published: June 11, 2025
Fewer relapses and worse outcomes of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 10, 2024
Causal associations between prodromal infection and neuromyelitis optica spectrum disorder: A Mendelian randomization study.
Journal: European journal of neurology
Published: April 20, 2023
Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 07, 2022
Baseline retinal nerve fiber layer thickness as a predictor of multiple sclerosis progression: New insights from the FREEDOMS II study.
Journal: European journal of neurology
Published: August 01, 2022
Development of fluorine-substituted NH2-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability.
Journal: Acta pharmaceutica Sinica. B
Published: June 12, 2022
Last Updated: 09/26/2026